ULTRA RAPID LISPRO (URLI) DEMONSTRATES SIMILAR TIME IN TARGET RANGE TO LISPRO WITH THE MEDTRONIC MINIMED 670G HYBRID CLOSED-LOOP SYSTEM

被引：0
|
作者：
Carlson, A. [1 ]
Liu, R. [2 ]
Hardy, T. [3 ]
Boyd, J. [4 ]
Bergenstal, R.
Morrett, S. [5 ]
Ignaut, D. [3 ]
机构：
[1] Int Diabet Ctr, Endocrinol, Minneapolis, MN USA
[2] Eli Lilly & Co, Global Stat Sci, Indianapolis, IN 46285 USA
[3] Eli Lilly & Co, Med Dev, Indianapolis, IN 46285 USA
[4] Atlanta Diabet Associates, Endocrinol, Atlanta, GA USA
[5] Eli Lilly & Co, Clin Dev Diabet, Indianapolis, IN 46285 USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P035 / #13
引用
收藏
页码：A85 / A86
页数：2
相关论文
共 48 条
  • [31] CamAPS FX Hybrid Closed-Loop with Ultra-Rapid Insulin Lispro Increases Time in Range Compared with Standard Insulin Lispro in Adults with Type 1 Diabetes-A Double-Blind, Randomized, Crossover Study
    Nwokolo, Munachiso
    Lakshman, Rama
    Boughton, Charlotte K.
    Ware, Julia
    Allen, Janet M.
    Wilinska, Malgorzata E.
    Alwan, Heba
    Evans, Mark
    Hovorka, Roman
    DIABETES, 2023, 72
  • [32] Real-World, Patient-Reported and Clinic Data from Individuals with Type 1 Diabetes Using the MiniMed 670G Hybrid Closed-Loop System
    DuBose, Stephanie N.
    Bauza, Colleen
    Verdejo, Alandra
    Beck, Roy W.
    Bergenstal, Richard M.
    Sherr, Jennifer
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (12) : 791 - 798
  • [33] THE INTRODUCTION OF MINIMED 670G HYBRID CLOSED LOOP INSULIN PUMP AUTO MODE SYSTEM IMPROVES GLYCAEMIC CONTROL IN ROUTINE CLINICAL PRACTICE
    Skvarca, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A177 - A177
  • [34] MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy
    Saunders, Aria
    Messer, Laurel H.
    Forlenza, Gregory P.
    EXPERT REVIEW OF MEDICAL DEVICES, 2019, 16 (10) : 845 - 853
  • [35] INTEGRATED INSULIN PUMP AND CONTINUOUS GLUCOSE MONITORING TECHNOLOGY IN DIABETES CARE TODAY: A PERSPECTIVE OF REAL-LIFE EXPERIENCE WITH THE MINIMED™ 670G HYBRID CLOSED-LOOP SYSTEM
    Aleppo, Grazia
    Webb, Kimberly M.
    ENDOCRINE PRACTICE, 2018, 24 (07) : 684 - 692
  • [36] Fast-acting insulin aspart (Fiasp®) improves glycemic outcomes when used with MiniMed™ 670G hybrid closed-loop system in simulated trials compared to NovoLog®
    Grosman, Benyamin
    Wu, Di
    Parikh, Neha
    Roy, Anirban
    Voskanyan, Gayane
    Kurtz, Natalie
    Sturis, Jeppe
    Cohen, Ohad
    Ekelund, Magnus
    Vigersky, Robert
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2021, 205
  • [37] Time-in-Target Glucose Range and the Glucose Management Indicator during Real-World MiniMed™ 670G System Use
    Gopalakrishnan, Shweta
    Cordero, Toni L.
    Sadeghzadeh, Mahta
    Stone, Michael
    Agrawal, Pratik
    DIABETES, 2019, 68
  • [38] Real world hybrid closed-loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months
    Messer, Laurel H.
    Berget, Cari
    Vigers, Tim
    Pyle, Laura
    Geno, Cristy
    Wadwa, R. Paul
    Driscoll, Kimberly A.
    Forlenza, Gregory P.
    PEDIATRIC DIABETES, 2020, 21 (02) : 319 - 327
  • [39] RAPID IMPROVEMENT IN TIME IN RANGE AFTER ADVANCED HYBRID CLOSED-LOOP SYSTEM INITIATION
    Beato-Vibora, P. I.
    Gallego-Gamero, F.
    Ambrojo-Lopez, A.
    Gil-Poch, E.
    Martin-Romo, I.
    Carrasco-Munoz, M.
    Arroyo-Diez, F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A79 - A79
  • [40] Increased proportion of time in hybrid closed-loop "Auto Mode" is associated with improved glycaemic control for adolescent and young patients with adult type 1 diabetes using the MiniMed 670G insulin pump
    Duffus, Sara H.
    Ta'ani, Zain Al
    Slaughter, James C.
    Niswender, Kevin D.
    Gregory, Justin M.
    DIABETES OBESITY & METABOLISM, 2020, 22 (04): : 688 - 693
12345